Browsing: RAassociated

Wellness Tips

Vutiglabridin overcomes the GLP-1 RA-associated weight-loss plateau to achieve normal body weight

By 0

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for body weight reduction, there remains a critical unmet need for complementary strategies that drive selective fat loss and sustain long-term weight reduction. This study aimed to investigate whether Vutiglabridin, a novel oral small-molecule anti-obesity drug, complements GLP-1 RAs to enhance therapeutic efficacy by selectively…